Home › Viral Infections › Ohio › Columbus
Viral Infections clinical trials in Columbus, OH
4 studies for Viral Infections are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Columbus
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Remington-Davis, Inc, Columbus
Third Party Viral Specific T-cells (VSTs)
RecruitingPhase 2
- The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
RecruitingPhase 1/2
- Nationwide Children's Hosptial, Columbus
About Viral Infections
Viruses cause familiar infections such as the common cold, but they also cause severe illnesses. Learn more about viral infections and their symptoms.
More about Viral Infections on MedlinePlus
Viral Infections trials in other cities
- Washington, DC12 studies
- Houston, TX6 studies
- Boston, MA6 studies
- Baltimore, MD5 studies
- Hialeah, FL5 studies
- Atlanta, GA4 studies
- Dallas, TX4 studies
- Cincinnati, OH4 studies
- San Francisco, CA3 studies
- St. Louis, MO3 studies
- Los Angeles, CA3 studies
- Tampa, FL3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.